Literature DB >> 20078481

Commentary on Larney (2010): a call to action-opioid substitution therapy as a conduit to routine care and primary prevention of HIV transmission among opioid-dependent prisoners.

Sandra A Springer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20078481      PMCID： PMC2825564          DOI： 10.1111/j.1360-0443.2009.02893.x

Source DB:  PubMed          Journal:  Addiction        ISSN： 0965-2140            Impact factor:   6.526


× No keyword cloud information.
  16 in total

1.  Incarceration and risk for HIV infection among injection drug users in Bangkok.

Authors:  Kachit Choopanya; Don C Des Jarlais; Suphak Vanichseni; Dwip Kitayaporn; Philip A Mock; Suwanee Raktham; Krit Hireanras; William L Heyward; Sathit Sujarita; Timothy D Mastro
Journal:  J Acquir Immune Defic Syndr       Date:  2002-01-01       Impact factor: 3.731

Review 2.  Interventions to reduce HIV transmission related to injecting drug use in prison.

Authors:  Ralf Jürgens; Andrew Ball; Annette Verster
Journal:  Lancet Infect Dis       Date:  2009-01       Impact factor: 25.071

3.  Incarceration experiences in a cohort of active injection drug users.

Authors:  M-J Milloy; Evan Wood; Will Small; Mark Tyndall; Calvin Lai; Julio Montaner; Thomas Kerr
Journal:  Drug Alcohol Rev       Date:  2008-11

4.  Revolving doors: imprisonment among the homeless and marginally housed population.

Authors:  Margot B Kushel; Judith A Hahn; Jennifer L Evans; David R Bangsberg; Andrew R Moss
Journal:  Am J Public Health       Date:  2005-10       Impact factor: 9.308

5.  Prevalence and incidence of HIV among incarcerated and reincarcerated women in Rhode Island.

Authors:  J D Rich; B P Dickinson; G Macalino; T P Flanigan; C W Towe; A Spaulding; D Vlahov
Journal:  J Acquir Immune Defic Syndr       Date:  1999-10-01       Impact factor: 3.731

6.  Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community.

Authors:  Sandra A Springer; Edward Pesanti; John Hodges; Thomas Macura; Gheorghe Doros; Frederick L Altice
Journal:  Clin Infect Dis       Date:  2004-05-26       Impact factor: 9.079

7.  A Study of Methadone Maintenance For Male Prisoners: 3-Month Postrelease Outcomes.

Authors:  Timothy W Kinlock; Michael S Gordon; Robert P Schwartz; Kevin E O'Grady
Journal:  Crim Justice Behav       Date:  2008

8.  Sexual behaviours of HIV-seropositive men and women following release from prison.

Authors:  Becky L Stephenson; David A Wohl; Rosemary McKaig; Carol E Golin; Lara Shain; Monica Adamian; Cathy Emrick; Ronald P Strauss; Cathie Fogel; Andrew H Kaplan
Journal:  Int J STD AIDS       Date:  2006-02       Impact factor: 1.359

9.  Accessing antiretroviral therapy following release from prison.

Authors:  Jacques Baillargeon; Thomas P Giordano; Josiah D Rich; Z Helen Wu; Katherine Wells; Brad H Pollock; David P Paar
Journal:  JAMA       Date:  2009-02-25       Impact factor: 56.272

10.  A pilot survey of attitudes and knowledge about opioid substitution therapy for HIV-infected prisoners.

Authors:  Sandra A Springer; Robert D Bruce
Journal:  J Opioid Manag       Date:  2008 Mar-Apr
View more
  6 in total

1.  Gender Differences in HIV Risk Behaviors Among Persons Involved in the U.S. Criminal Justice System and Living with HIV or at Risk for HIV: A "Seek, Test, Treat, and Retain" Harmonization Consortium.

Authors:  Kelsey B Loeliger; Mary L Biggs; Rebekah Young; David W Seal; Curt G Beckwith; Irene Kuo; Michael S Gordon; Frederick L Altice; Lawrence J Ouellet; William E Cunningham; Jeremy D Young; Sandra A Springer
Journal:  AIDS Behav       Date:  2017-10

2.  Public health implications for adequate transitional care for HIV-infected prisoners: five essential components.

Authors:  Sandra A Springer; Anne C Spaulding; Jaimie P Meyer; Frederick L Altice
Journal:  Clin Infect Dis       Date:  2011-09       Impact factor: 9.079

3.  Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community.

Authors:  Angela Di Paola; Thomas Lincoln; Daniel J Skiest; Maureen Desabrais; Frederick L Altice; Sandra A Springer
Journal:  Contemp Clin Trials       Date:  2014-09-18       Impact factor: 2.226

4.  Correlates of retention on extended-release naltrexone among persons living with HIV infection transitioning to the community from the criminal justice system.

Authors:  Sandra A Springer; Shan-Estelle Brown; Angela Di Paola; Frederick L Altice
Journal:  Drug Alcohol Depend       Date:  2015-10-28       Impact factor: 4.492

Review 5.  Antiretroviral therapy in prevention of HIV and TB: update on current research efforts.

Authors:  Reuben Granich; Somya Gupta; Amitabh B Suthar; Caoimhe Smyth; David Hoos; Marco Vitoria; Mariangela Simao; Catherine Hankins; Bernard Schwartlander; Renee Ridzon; Brigitte Bazin; Brian Williams; Ying-Ru Lo; Craig McClure; Julio Montaner; Gottfried Hirnschall
Journal:  Curr HIV Res       Date:  2011-09       Impact factor: 1.581

6.  Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisoners.

Authors:  Sandra A Springer; Jingjun Qiu; Ali Shabahang Saber-Tehrani; Frederick L Altice
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.